KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to -$6.0 billion.

  • Bristol Myers Squibb's Cash from Financing Activities fell 26717.42% to -$6.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$10.3 billion, marking a year-over-year decrease of 30183.34%. This contributed to the annual value of -$10.3 billion for FY2025, which is 30183.34% down from last year.
  • Bristol Myers Squibb's Cash from Financing Activities amounted to -$6.0 billion in Q4 2025, which was down 26717.42% from -$1.5 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Cash from Financing Activities ranged from a high of $14.6 billion in Q1 2024 and a low of -$7.3 billion during Q1 2021
  • For the 5-year period, Bristol Myers Squibb's Cash from Financing Activities averaged around -$2.4 billion, with its median value being -$3.2 billion (2021).
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first plummeted by 59212.52% in 2021, then skyrocketed by 58013.11% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Cash from Financing Activities stood at -$4.0 billion in 2021, then increased by 18.17% to -$3.2 billion in 2022, then surged by 129.79% to $967.0 million in 2023, then tumbled by 269.8% to -$1.6 billion in 2024, then plummeted by 267.17% to -$6.0 billion in 2025.
  • Its Cash from Financing Activities was -$6.0 billion in Q4 2025, compared to -$1.5 billion in Q3 2025 and -$1.8 billion in Q2 2025.